SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-016474
Filing Date
2021-07-08
Accepted
2021-07-08 17:02:16
Documents
4
Period of Report
2021-07-08

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 16498
2 ex99-1.htm EX-99.1 1778
3 ex99-1_001.jpg GRAPHIC 86098
4 ex99-1_002.jpg GRAPHIC 39935
  Complete submission text file 0001493152-21-016474.txt   193157
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 6-K | Act: 34 | File No.: 001-40101 | Film No.: 211080863
SIC: 2834 Pharmaceutical Preparations